Douglas Yee, MD

Director, Masonic Cancer center, University of Minnesota

neuveo clinical advisory board

Dr. Yee is a professor in the Departments of Medicine and Pharmacology, Dr. Yee holds the John H. Kersey Chair in Cancer Research.  Dr. Yee’s curriculum vitae includes well over 210 publications.  He also maintains an active clinical practice in breast medical oncology at the Breast Center, University of Minnesota Medical Center. 

Dr. Yee has served on numerous national grant review and policy panels including the National Cancer Institute’s Cancer Center Parent Committee.  Dr. Yee is a Pew Scholar and a Komen Scholar with the Susan G Komen for the Cure and has been a co-investigator on a V Foundation Translational Research Grant.  He has an active leadership role in the ISPY-2 clinical trial.  Dr. Yee is also a member of the Scientific Advisory Committee for the Love/Avon Army of Women.  He also serves as an external advisor for several NCI-designated cancer centers. 

Dr. Yee graduated from the University of Michigan in Ann Arbor, earned his medical degree from the University of Chicago, and completed his residency in internal medicine at the University of North Carolina in Chapel Hill and completed his fellowship in medical oncology at the National Cancer Institute in Bethesda, MD.  Before coming to the University of Minnesota, he held faculty positions in the Lombardi Cancer Center at Georgetown University in Washington, D.C., and at the University of Texas Health Science Center in San Antonio.

 
Neumannjpg.jpg

kurt neumann, md, FACP

Medical oncology, hematology

neuveo clinical advisory board

Dr. Neumann has over three decades of community and health system oncology experience and an expertise in facilitating provider and payer relations.  He was Vice Chair of Corporate Medical Oncology at William Beaumont Hospital in Royal Oak, Michigan where he helped develop a private practice-oncology service line co-management model. He has also served as director of Oncologic Services and Director of Hospice while serving as senior managing partner at Hematology Oncology Consultants, P.C.  where he practiced for more than 25 years. He has served as charter board member, president, and Oncology Advisory Panel member of the Michigan Society of Hematology and Oncology and for Oncology Physician Resource in support of Michigan community oncology practices.  He has served as Medical Director for Quality Initiatives and as an Executive Clinical Advisor for national oncology related enterprises.

Dr. Neumann graduated with high distinction from the University of Michigan and MD cum laude from Harvard Medical School. He completed his post graduate training including hematology and oncology fellowships at the University of California San Francisco. In addition to his MSHO volunteer commitments, Neumann has served as a board member of Hospice of Southeastern Michigan.

 
Michael_head_shot.jpg

Michael Oelze, PhD

University of Illinois Urbana-Champaign

Neuveo Scientific Advisory Board

Professor Oelze earned a B.S. in Physics and Mathematics in 1994 from Harding University and Ph.D. in Physics in 2000 from University of Mississippi. From 2000 to 2002 Dr. Oelze served as a post-doc in the Bioacoustics Research Laboratory at the University of Illinois at Urbana-Champaign (UIUC). From 2002 to 2004, Dr. Oelze was a NIH fellow conducting research in quantitative ultrasound techniques for biomedical ultrasound applications in cancer detection. Dr. Oelze joined the ECE faculty at the UIUC in 2005 and continues to serve as an associate professor.

His research interests include biomedical ultrasound, quantitative ultrasound imaging for improving cancer diagnostics and monitoring therapy response, ultrasound bioeffects, ultrasound tomography techniques, ultrasound-based therapy, beam forming and applications of coded excitation to ultrasonic imaging. Currently, Dr. Oelze is a fellow of the AIUM, a senior member of the IEEE, and a member of ASA. He also serves as an associate editor of IEEE Transactions on Ultrasonic, Ferroelectrics, and Frequency Control, associate editor of Ultrasonic Imaging and associate editor for IEEE Transactions on Biomedical Engineering.

 

 

Olivier Gevaert, PhD

Stanford University

Neuveo Scientific Advisory Board

Dr. Olivier Gevaert is an assistant professor at Stanford University focusing on developing machine-learning methods for biomedical decision support from multi-scale biomedical data. He is an electrical engineer by training with additional training in artificial intelligence, and a PhD in bioinformatics at the University of Leuven, Belgium. He continued his work as a postdoc in radiology at Stanford and started his lab at the Department of Medicine, Biomedical Informatics. His lab focuses on multi-scale biomedical data fusion primarily in oncology and neuroscience.

Professor Gevaert's lab draws upon machine learning methods such as Bayesian methods, kernel methods and regularized regression to integrate molecular data or omics such as (epi)genomics, transcriptomics, proteomics, etc. Moreover, the lab also investigates strategies to couple these omics data with phenotypes at cellular and tissue scales using pathological imaging and medical imaging data (e.g. MRI, PET, CT, ...) in the context of computational pathology, imaging genomics & radiogenomics.